April 15 2025
NRG Oncology has multiple active trials currently available to patients with head and neck cancer. All active NRG Oncology clinical trials can be found on our website protocol search page.
NRG-CC013
Status: Temporarily closed to accrual
Study Name: A Randomized, Masked, Placebo Controlled, Phase II Trial Of Concurrent Chemoradiation With BMX-001 In Patients With Head And Neck Squamous Cell Carcinoma Receiving Concurrent Chemoradiation
Trial Webpage | Patient Study Webpage | Patient Study Brochure
NRG-HN006
Status: Temporarily closed to accrual
Study Name: Randomized Phase II/III Trial Of Sentinel Lymph Node Biopsy Versus Elective Neck Dissection For Early-Stage Oral Cavity Cancer
Trial Webpage | Patient Study Webpage | Patient Study Brochure
NRG-HN009
Status: Open to accrual
Study Name: Randomized Phase II/III Trial of Radiation with High-Dose Cisplatin (100 mg/m2) Every Three Weeks versus Radiation with Low-Dose Weekly Cisplatin (40 mg/m2) for Patients with Locoregionally Advanced Squamous Cell Carcinoma of The Head And Neck (SCCHN)
Trial Webpage | Patient Study Webpage | Patient Study Brochure
NRG-HN010
Status: Open to accrual
Study Name: A Controlled, Randomized Phase II Trial of Docetaxel Plus Trastuzumab Versus Ado-Trastuzumab Emtansine for Recurrent, Metastatic, or Treatment-Naïve, Unresectable Her2-Positive Salivary Gland Cancer
Trial Webpage | Patient Study Webpage | Patient Study Brochure
NRG-HN011
Status: Open to accrual
Study Name: A Randomized Phase II Study of Nivolumab versus Nivolumab and BMS-986016 (Relatlimab) as Maintenance Treatment after First-line Treatment with Platinum-Gemcitabine-Nivolumab for Patients with Epstein-Barr Virus-Associated Recurrent/Metastatic Nasopharyngeal Carcinoma (REMAIN)
Trial Webpage | Patient Study Webpage | Patient Study Brochure
NRG-HN014
Status: Open to accrual
Study Name: Randomized Phase III Trial of Neoadjuvant Immunotherapy With Response-Adapted Treatment Versus Standard-of-Care Treatment for Resectable Stage III/IV Cutaneous Squamous Cell Carcinoma
Trial Webpage | Patient Study Webpage | Patient Study Brochure
NRG-RTOG 1216
Status: Open to accrual
Study Name: Randomized Phase II/III Trial of Adjuvant Radiation Therapy with Cisplatin, Docetaxel-Cetuximab, or Cisplatin-Atezolizumab in Pathologic High-Risk Squamous Cell Cancer of the Head and Neck
Trial Webpage